Serum bilirubin subgroups and cancer risk: Insights with a focus on lung cancer

Menée à l'aide de données coréennes portant sur 133 630 personnes (durée moyenne de suivi : 13,5 ans), cette étude analyse l'association entre les niveaux sériques de bilirubine et le risque de cancer du poumon en fonction du sexe

Résumé en anglais

Background: Bilirubin is a potent antioxidant that neutralizes reactive oxygen species (ROS). While previous studies have predominantly focused on the association between total bilirubin and cancer risk, this study evaluates the association of different bilirubin subgroups with cancer risk in men and women.

Methods: Data were derived from the Korean Cancer Prevention Study-II cohort, including 133,630 participants. Over a mean follow-up of 13.5 years, 9876 cancer cases were identified. Serum bilirubin levels (total, indirect, direct) were categorized into sex-specific quartiles and analyzed. Cox proportional hazard models were used to estimate hazard ratios (HR) and 95 % confidence intervals (CI), along with trend analyses.

Results: In men, a 1 standard deviation (SD) increase in total bilirubin was inversely associated with lung cancer risk (HR: 0.82, 95 % CI: 0.74–0.91), and direct bilirubin showed an inverse association (HR: 0.83, 95 % CI: 0.74–0.93). In contrast, in women, a 1 SD increase in total bilirubin was positively associated with lung cancer risk (HR: 1.15, 95 % CI: 1.00–1.32). Among male smokers, a 1 SD increase in total bilirubin (≥30 cigarettes/day) was inversely associated with lung cancer risk (HR: 0.73, 95 % CI: 0.55–0.97), and a 1 SD increase in direct bilirubin (10–19 cigarettes/day) showed an inverse association (HR: 0.79, 95 % CI: 0.63–0.99).

Conclusions: In men, both total and direct bilirubin levels were inversely associated with lung cancer risk, whereas in women, total bilirubin was positively associated with lung cancer risk.